CAS号:356068-94-5
品名:托西尼布Toceranib
中文别名:托西尼布
英文别名:5-(5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylicacid(2-pyrrolidin-1-yl-ethyl)-amide;5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide;5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide;
分子式:C22H25FN4O2
分子量:396.458
精确质量:396.196
Psa:77.23
MDL号:MFCD16038046
密度:
储存条件:-20C
简介:Toceranibisareceptortyrosinekinaseinhibitorandisusedinthetreatmentofcaninemastcelltumoralsocalledmastocytoma.Togetherwithmasitinib(Kinavet(US)/Masivet(EU/ROW)byABScience),toceranibistheonlydog-specificanti-cancerdrugapprovedbytheU.S.FoodandDrugAdministration.ItismarketedasPalladiaasitsphosphatesalt,toceranibphosphate(INN)byPfizer.ItwasdevelopedbySUGENasSU11654,asistercompoundtosunitinib,whichwaslaterapprovedforhumantherapies.Toceranibislikelytoactmostlythroughinhibitionofthekittyrosinekinase,thoughitmayalsohaveananti-angiogeniceffect.
蛋白酪氨酸激酶